Cochlear Ltd
COH: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| CKw | LOCK|$p | LOCK|^Y<%c$<L |
Cochlear: Profit Target Looks Too Ambitious
Cochlear reaffirmed fiscal 2027 guidance for low-single-digit constant-currency revenue growth and AUD 330 million to AUD 350 million in underlying net profit. Developed-market implant volumes grew at a mid-single-digit rate from July to October, in line with management's expectations.
